Home > Share Market > Stocks > Balaxi pharmaceuticals > Financial Statements> BALAXI Profit & Loss

Balaxi Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Balaxi Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Revenue 279 231 45.60 13.60
yoy growth (%) 20.80 407 236 --
Raw materials (196) (172) (34) (10)
As % of sales 70 74.40 73.60 75.30
Employee costs (12) (8.50) (2.10) (0.90)
As % of sales 4.46 3.66 4.60 6.63
Other costs (21) (8.30) (3.90) (0.90)
As % of sales 7.56 3.59 8.52 6.63
Operating profit 50.20 42.40 6.07 1.56
OPM 18 18.30 13.30 11.40
Depreciation (0.50) (0.30) -- --
Interest expense (0.10) -- -- --
Other income 4.97 2.23 2.81 0.89
Profit before tax 54.50 44.30 8.87 2.44
Taxes (6.90) (6.20) (2.80) (0.50)
Tax rate (13) (14) (31) (19)
Minorities and other -- -- -- --
Adj. profit 47.70 38.10 6.10 1.97
Exceptional items -- -- -- --
Net profit 47.70 38.10 6.10 1.97
yoy growth (%) 25 525 210 --
NPM 17.10 16.50 13.40 14.50

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000